How do you measure and interpret in practice the combined measurement of insulin sensitivity and β secretion function?;Comment mesurer et interpréter en pratique la mesure combinée de la sensibilité a l'insuline et de la fonction sécré toire β?

Louvain Medical

Volumn 125, Issue 3, 2006, Pages

  Hermans, Michel P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONFERENCE PAPER; DYSLIPIDEMIA; FETAL MALNUTRITION; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; OBESITY; PHENOTYPE;

EID: 33645761397     PISSN: 00246956     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Bergman RN, Watanabe R, Rebrin K, Ader M, Steil G: Toward an integrated phenotype in pre-NIDDM. Diabet Med. 1996; 13 (Suppl 6): S67-S77.
2. Bergman RN, Ader M, Huecking K, Van Citters G: Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002; 51 (Suppl 1): S212-S220.
3. Bergman RN: Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med. 2002; 69: 280-290.
4. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW et al.: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993; 42: 1663-1672.
5. Hermans MP, Dumont C, Buysschaert M: Clinical, biophysical and biochemical variables from African-heritage subjects with type 2 diabetes. Acta Clin Belg. 2002; 57: 134-141.
6. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia. 1999; 42: 678-687.
7. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes. 1999; 48: 1779-1786.
8. Hermans MP, Pepersack TM, Godeaux LH, Beyer I, Turc AP: Prevalence and determinants of impaired glucose metabolism in frail elderly patients: the Belgian Elderly Diabetes Survey (BEDS). J Gerontol A Biol Sci Med Sci. 2005; 60: 241-247.
9. Hermans MP, Selvais PL: Characterization of type 2 diabetes mellitus in first generation Italian migrants to Belgium. Acta Clin Belg. 2005; 60: 362-368.
10. Kuo CS, Hwu CM, Kwok CF, Hsiao LC, Weih MJ, Lee SH, Lee YS, Ho LT: Surrogate estimates of insulin sensitivity in Chinese diabetic patients and their offspring. Diabet Med. 2002; 19: 735-740.
11. Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med. 1998; 15: 290-296.
12. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998; 21: 2191-2192.
13. Richards RJ: Regarding the use of HOMA to aid drug selection. Diabet Med. 2005; 22: 225-228.
14. Taverna MJ, Pacher N, Bruzzo F, Slama G, Selam JL: Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes. Diabet Med. 2001; 18: 584-588.